PubRank

P Walden

Author PubWeight™ 48.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exact prediction of a natural T cell epitope. Eur J Immunol 1991 2.90
2 Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J Immunol 1996 2.70
3 Retracted Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med 2000 2.64
4 T-cell epitope mapping by flow cytometry. Nat Med 1998 2.56
5 Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J Med Vet Mycol 1993 2.47
6 Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 1992 1.76
7 A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. Proc Natl Acad Sci U S A 1993 1.63
8 Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma: evidence for possible superantigen involvement. Br J Dermatol 2004 1.53
9 An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 2000 1.42
10 Induction of regulatory T-lymphocyte responses by liposomes carrying major histocompatibility complex molecules and foreign antigen. Nature 1985 1.34
11 Collaboration of helper and cytotoxic T lymphocytes. Eur J Immunol 1993 1.08
12 Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J Exp Med 1995 1.05
13 Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc Natl Acad Sci U S A 1996 0.97
14 Detection and quantification of CD4(+) T cells with specificity for a new major histocompatibility complex class II-restricted influenza A virus matrix protein epitope in peripheral blood of influenza patients. J Virol 2000 0.97
15 Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int J Cancer 2000 0.95
16 Analysis of a naturally occurring HLA class I-restricted viral epitope. Immunology 1994 0.94
17 Tolerance to amino acid variations in peptides binding to the major histocompatibility complex class I protein H-2Kb. J Biol Chem 1995 0.91
18 Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines. Biochim Biophys Acta 2000 0.91
19 Combined laser tweezers and dielectric field cage for the analysis of receptor-ligand interactions on single cells. Electrophoresis 2001 0.91
20 Identification of the testis-specific protein 10 (TSGA10) as serologically defined tumour-associated antigen in primary cutaneous T-cell lymphoma. Br J Dermatol 2005 0.88
21 Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL. J Immunol 1996 0.87
22 Determination of T cell epitopes with random peptide libraries. J Immunol Methods 1996 0.85
23 Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries. Eur J Immunol 2001 0.85
24 Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries. J Biol Chem 1998 0.85
25 Antigen presentation by liposomes: inhibition with antibodies. Eur J Immunol 1986 0.83
26 Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. J Immunol Methods 1994 0.82
27 Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein. Urology 2001 0.80
28 Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice. Eur J Immunol 1993 0.80
29 A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma. Ann Oncol 2000 0.80
30 CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression. J Immunol 1994 0.80
31 Residual minor histocompatibility genes contaminate the B10.AM congenic line: no evidence of C-region-controlled histoincompatibility. Scand J Immunol 1983 0.80
32 T cell receptor specificity and mimotopes. Curr Opin Immunol 1999 0.79
33 Distribution of alloreactivity among antigen-specific, class II-restricted T-cell clones and hybridomas. Immunogenetics 1985 0.79
34 Electrophoresis-related protein modification: alkylation of carboxy residues revealed by mass spectrometry. Electrophoresis 1998 0.79
35 Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes. Cancer Immunol Immunother 1994 0.78
36 Peptide binding to MHC class I molecules analyzed by confocal microscopy. Eur J Cell Biol 1995 0.77
37 Peptide length preferences for rat and mouse MHC class I molecules using random peptide libraries. Eur J Immunol 1998 0.77
38 Identification of epitopes for CTCL-specific cytotoxic T lymphocytes. Adv Exp Med Biol 1998 0.77
39 Cancer stem cells in melanoma. Ecancermedicalscience 2008 0.77
40 Cutaneous malignant lymphomas. Immunol Today 1998 0.76
41 Hybrid cell vaccination in cancer immunotherapy. Recruitment and activation of T cell help for induction of anti tumour cytotoxic T cells. Adv Exp Med Biol 1998 0.76
42 Molecular characterization of signalling pathways in cancer stem cells. Ecancermedicalscience 2008 0.75
43 Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice. Immunology 1995 0.75
44 Incorrect attribution of peptide source. Cell 1993 0.75
45 A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma. Adv Exp Med Biol 1998 0.75
46 Gene therapy of cancer. Immunol Today 1998 0.75
47 WHAT CAN THE MODERN CHEMIST LEARN FROM THE OLD ALCHEMY? Science 1927 0.75
48 New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules. J Biol Chem 1998 0.75
49 Beta-delayed deuteron emission from (11)Li: decay of the halo. Phys Rev Lett 2008 0.75
50 The future of vaccination as a treatment strategy in dermatological diseases. Clin Exp Dermatol 2002 0.75
51 Amino acid preferences in the octapeptide subunit of the major histocompatibility complex class I heterotrimer H-2Ld. Eur J Biochem 1996 0.75
52 Measurement of the two-halo neutron transfer reaction (1)H((11)Li, (9)Li)(3)H at 3A MeV. Phys Rev Lett 2008 0.75
53 Antigen presentation by liposomes. Haematol Blood Transfus 1985 0.75
54 N-Hydroxy-amide analogues of MHC-class I peptide ligands with nanomolar binding affinities. J Pept Sci 1998 0.75
55 H-2 haplotypes carrying identical D but different L alleles. Tissue Antigens 1983 0.75
56 Mimetics of a T cell epitope based on poly-N-acylated amine backbone structures induce T cells in vitro and in vivo. J Biol Chem 2001 0.75
57 T cell response to myoglobin: a comparison of T cell clones in high-responder and low-responder mice. Eur J Immunol 1988 0.75
58 The hybrid cell vaccination approach to cancer immunotherapy. Ernst Schering Res Found Workshop 2000 0.75
59 Altered allogeneic response in neonatally anti-MHC class I-treated mice. Scand J Immunol 1996 0.75
60 Composition of a suppressor factor that inhibits the immune response to lactate dehydrogenase B. Scand J Immunol 1984 0.75
61 Breast cancer trials--a new initiative. Br Med J 1980 0.75
62 Cutting edge: N-hydroxy peptides: a new class of TCR antagonists. J Immunol 1999 0.75
63 Measurement of the 18Ne(α,p0) 21Na reaction cross section in the burning energy region for x-ray bursts. Phys Rev Lett 2012 0.75
64 Retrograde ejaculation. Lancet 1969 0.75
65 Fine specificity analysis of lactate dehydrogenase B-specific proliferating T cell clones: implications for the mechanism of alloreactivity. Eur J Immunol 1985 0.75
66 Hybrid cell vaccination in patients with metastatic melanoma. Methods Mol Med 2000 0.75
67 Do halo nuclei follow Rutherford elastic scattering at energies below the barrier? The case of 11Li. Phys Rev Lett 2012 0.75